AUROPHARMA.NSE logoAUROPHARMA.NSE
Aurobindo Pharma Ltd.

406
Loading...
Loading...
Upcoming Earnings: Q2 '25
Reports: Nov 06,
After Hours

Estimated EPS

15.58

Estimated Rev

80.86B

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '25
15.58
--
--
N/A
Q1 '25
16.68
14.20
-14.88%
MISSED
Q4 '24
17.68
15.56
-12.00%
MISSED
Q3 '24
15.54
14.56
-6.33%
MISSED
Q2 '24
16.05
14.00
-12.75%
MISSED

Latest AUROPHARMA.NSE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.